The retinoblastoma tumour suppressor in development and cancer
The DOI matches its Crossref record; 133 of the 133 references it cites were found in a registry or an index.
Abstract
Since its discovery, the retinoblastoma (RB) tumour-suppressor protein has been a focal point of cancer research. Accumulating evidence indicates a complex role for RB in cell proliferation, differentiation and survival. To further complicate matters, proteins that are related to RB have redundant as well as antagonistic functions. Recent studies of knockout mice and cells that lack one or more of these proteins have begun to clarify their various context-specific functions and the unique activity of this tumour suppressor.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The role of RB in promoting cellular differentiation during embryonic development and in adult lineages has been well characterized in mutant mice and in vitro systems20,42,58–61.”
From Cellular mechanisms of tumour suppression by the retinoblastoma gene (2008) · cites this paper as [61]
In the citing paper
“The growth suppressive properties of Rb are largely, but not completely, associated with its binding to the transcription factor E2F and repressing transcription at target promoters (Classon and Harlow, 2002; Harbour and Dean, 2000; Stevaux and Dyson, 2002).”
From CDK4/6 Inhibitors: The Mechanism of Action May Not Be as Simple as Once Thought (2018) · cites this paper as Classon and Harlow, 2002
In the citing paper
“In virtually all human cancer cells, this circuit is dysregulated by either overexpression of cyclin D1, loss of p16Ink4a, the mutation of CDK4 to an Ink4-refractory state, or the loss of Rb itself (Classon and Harlow, 2002).”
From CDK4/6 Inhibitors: The Mechanism of Action May Not Be as Simple as Once Thought (2018) · cites this paper as Classon and Harlow, 2002
Citations
Cites
Sherr, C. J. (1996) · Science · doi:10.1126/science.274.5293.1672 · Cited by 5,379 · cited 1×
“RB is therefore linked directly to the intricate regulatory network that controls cell-cycle progressio”
BackgroundA human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma
Friend, S. H., Bernards, R., Rogelj, S., Weinberg, R. A., Rapaport, J. M., Albert, D. M., & Dryja, T. P. (1986) · Nature · doi:10.1038/323643a0 · Cited by 2,948
The regulation of E2F by pRB-family proteins.
Dyson, N. (1998) · Genes & Development · doi:10.1101/gad.12.15.2245 · Cited by 2,317
Weinberg, R. A. (1991) · Science · doi:10.1126/science.1659741 · Cited by 1,756
Effects of an Rb mutation in the mouse
Jacks, T., Fazeli, A., Schmitt, E. M., Bronson, R. T., Goodell, M. A., & Weinberg, R. A. (1992) · Nature · doi:10.1038/359295a0 · Cited by 1,755
E2F: a Link Between the Rb Tumor Suppressor Protein and Viral Oncoproteins
Nevins, J. R. (1992) · Science · doi:10.1126/science.1411535 · Cited by 1,506
DeCaprio, J. A., Ludlow, J. W., Figge, J., Shew, J.-Y., Huang, C.-M., Lee, W.-H., Marsilio, E., Paucha, E., & Livingston, D. M. (1988) · Cell · doi:10.1016/0092-8674(88)90559-4 · Cited by 1,459 · cited 1×
“These findings indicated that RB is a regulator of cell proliferatio”
BackgroundHuman Retinoblastoma Susceptibility Gene: Cloning, Identification, and Sequence
Lee, W.-H., Bookstein, R., Hong, F., Young, L.-J., Shew, J.-Y., & Lee, E. Y.-H. P. (1987) · Science · doi:10.1126/science.3823889 · Cited by 1,417
Whyte, P., Buchkovich, K. J., Horowitz, J. M., Friend, S. H., Raybuck, M., Weinberg, R. A., & Harlow, E. (1988) · Nature · doi:10.1038/334124a0 · Cited by 1,403
Self-citationMice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis
Lee, E. Y.-H. P., Chang, C.-Y., Hu, N., Wang, Y.-C. J., Lai, C.-C., Herrup, K., Lee, W.-H., & Bradley, A. (1992) · Nature · doi:10.1038/359288a0 · Cited by 1,265
Research works printed but not linked: 4
- Guo, Z., Yikang, S., Yoshida, H., Mak, T. W. & Zacksenhaus, E. Inactivation of the retinoblastoma tumor suppressor induces Apaf-1 dependent and independent apoptotic pathways during embryogenesis. Cancer Res. 61, 8395–8400 (2001).
- Guo, Z., Yikang, S., Yoshida, H., Mak, T. & Zacksenhaus, E. Inactivation of the retinoblastoma tumor suppressor induces Apaf-1 dependent and independent apoptotic pathways during embryogenesis. Cancer Res. 61, 8395–8400 (2001).
- Vooijs, M. & Berns, A. Developmental defects and tumor predisposition in Rb mutant mice. Oncogene 18, 5293–5303 (1999). · DOI
- Elliott, M. J., Dong, Y. B., Yang, H. & McMasters, K. M. E2F-1 upregulates c-Myc and p14ARF and induces apoptosis in colon cancer cells. Clin. Cancer Res. 7, 3590–3597 (2001).
Cited by
Cancer genes and the pathways they control
Vogelstein, B., & Kinzler, K. W. (2004) · Nature Medicine · doi:10.1038/nm1087 · Cited by 4,249
“The products of these genes include proteins as diverse as cdk4 (a kinase), cyclin D1 (which interacts with and activates cdk4), Rb (a transcription factor) and p16 (which interacts with and inhibits cdk4”
BackgroundTreating cancer with selective CDK4/6 inhibitors
O'Leary, B., Finn, R. S., & Turner, N. C. (2016) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2016.26 · Cited by 1,137
Cellular mechanisms of tumour suppression by the retinoblastoma gene
Burkhart, D. L., & Sage, J. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2399 · Cited by 974
“The role of RB in promoting cellular differentiation during embryonic development and in adult lineages has been well characterized in mutant mice and in vitro system”
BackgroundDoes the ribosome translate cancer?
Ruggero, D., & Pandolfi, P. P. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1015 · Cited by 928
“Its function as tumour suppressor has been attributed to its ability to regulate the cell cycle, which involves modulation of the transcriptional activity of E2”
BackgroundMammalian cells cycle without the D-type cyclin-dependent kinases Cdk4 and Cdk6
Malumbres, M., Sotillo, R., Santamarı́a, D., Galán, J., Cerezo, A., Ortega, S., Dubus, P., & Barbacid, M. (2004) · Cell · doi:10.1016/j.cell.2004.08.002 · Cited by 793
The E2F transcriptional network: old acquaintances with new faces
Dimova, D. K., & Dyson, N. J. (2005) · Oncogene · doi:10.1038/sj.onc.1208612 · Cited by 715
“Further support comes from studies of mice carrying mutant alleles of RB and E2F family members (reviewed in Lipinski and Jacks, 1999; Nevins, 2001; Classon and Dyson, 2001; Classon and Harlow, 2002; DeGregori, 2002; Cam and Dynlacht, 2003).”
BackgroundReactome: a knowledge base of biologic pathways and processes
Vastrik, I., D'Eustachio, P., Schmidt, E., Joshi-Tope, G., Gopinath, G., Croft, D., de Bono, B., Gillespie, M., Jassal, B., Lewis, S., et al. (2007) · Genome Biology · doi:10.1186/gb-2007-8-3-r39 · Cited by 654
Meuwissen, R., Linn, S. C., Linnoila, R. I., Zevenhoven, J., Mooi, W. J., & Berns, A. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00220-4 · Cited by 643
p38 MAP kinase inhibition enables proliferation of adult mammalian cardiomyocytes
Engel, F. B., Schebesta, M., Duong, M. T., Lu, G., Ren, S., Madwed, J. B., Jiang, H., Wang, Y., & Keating, M. T. (2005) · Genes & Development · doi:10.1101/gad.1306705 · Cited by 595
“Finally, p38 inhibitor and FGF1, but neither factor alone, led to phosphorylation of Rb, a key cell cycle regulator (Fig. 1C,D; Classon and Harlow 2002).”
BackgroundMolecular mechanisms underlying RB protein function
Dick, F. A., & Rubin, S. M. (2013) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3567 · Cited by 569
Acute mutation of retinoblastoma gene function is sufficient for cell cycle re-entry
Sage, J., Miller, A. L., Pérez-Mancera, P. A., Wysocki, J. M., & Jacks, T. (2003) · Nature · doi:10.1038/nature01764 · Cited by 538
“However, this compensation is difficult to reconcile with the fact that, whereas RB mutations are common in human cancer, p107 and p130 mutations occur rarely, if eve”
BackgroundTelomeres, stem cells, senescence, and cancer
Sharpless, N. E., & DePinho, R. A. (2004) · Journal of Clinical Investigation · doi:10.1172/jci20761 · Cited by 473
The p53 network: cellular and systemic DNA damage responses in aging and Cancer
Reinhardt, H. C., & Schumacher, B. (2012) · Trends in Genetics · doi:10.1016/j.tig.2011.12.002 · Cited by 458
DNA tumor virus oncogenes antagonize the cGAS-STING DNA-sensing pathway
Lau, L., Gray, E. E., Brunette, R. L., & Stetson, D. B. (2015) · Science · doi:10.1126/science.aab3291 · Cited by 453
Regulating tumor suppressor genes: post-translational modifications
Chen, L., Liu, S., & Tao, Y. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0196-9 · Cited by 449
Braal, C. L., Jongbloed, E. M., Wilting, S. M., Mathijssen, R. H. J., Koolen, S. L. W., & Jager, A. (2021) · Drugs · doi:10.1007/s40265-020-01461-2 · Cited by 438
Litovchick, L., Sadasivam, S., Florens, L., Zhu, X., Swanson, S. K., Velmurugan, S., Chen, R., Washburn, M. P., Liu, X. S., & DeCaprio, J. A. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.04.015 · Cited by 396
“Interestingly, while inactivating mutations in upstream regulators of RB pathway are found in many human cancers, only pRB incurs specific loss-of-function mutations and acts as a bona fide tumor suppressor (Classon and Harlow, 2002; Wikenheiser-Brokamp, 2006).”
BackgroundDissecting the Unique Role of the Retinoblastoma Tumor Suppressor during Cellular Senescence
Chicas, A., Wang, X., Zhang, C., McCurrach, M., Zhao, Z., Mert, O., Dickins, R. A., Narita, M., Zhang, M., & Lowe, S. W. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.01.023 · Cited by 388
“Studies using both biochemical and genetic approaches have identified distinct and overlapping functions of each family member (Classon and Harlow, 2002).”
Inhibitors of cyclin-dependent kinases as cancer therapeutics.
Whittaker, S. R., Mallinger, A., Workman, P., & Clarke, P. A. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.02.008 · Cited by 384
“Early studies showed that RB exists in a hypophosphorylated state in quiescent cells and that its phosphorylation in response to mitogens is associated with progression through the cell cycle (Classon & Harlow, 2002).”
CDK4/6 Inhibitors: The Mechanism of Action May Not Be as Simple as Once Thought
Klein, M. E., Kovatcheva, M., Davis, L. E., Tap, W. D., & Koff, A. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.03.023 · Cited by 378
“The growth suppressive properties of Rb are largely, but not completely, associated with its binding to the transcription factor E2F and repressing transcription at target promoters (Classon and Harlow, 2002; Harbour and Dean, 2000; Stevaux and Dyson, 2002).”
BackgroundChemotherapy resistance in osteosarcoma: current challenges and future directions
Chou, A. J., & Gorlick, R. (2006) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.6.7.1075 · Cited by 377
Lineage dependency and lineage-survival oncogenes in human cancer
Garraway, L. A., & Sellers, W. R. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1947 · Cited by 360
Tailoring to RB: tumour suppressor status and therapeutic response
Knudsen, E. S., & Knudsen, K. E. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2401 · Cited by 344
“gov/cancertopics/types/retinoblastoma">retinoblastoma (RB) tumour suppressor protein, whose primary function is to prevent unscheduled entry into the mitotic cell cycl”
A Kinase-Independent Function of CDK6 Links the Cell Cycle to Tumor Angiogenesis
Kollmann, K., Heller, G., Schneckenleithner, C., Warsch, W., Scheicher, R., Ott, R. G., Schäfer, M., Fajmann, S., Schlederer, M., Schiefer, A.-I., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.07.012 · Cited by 313
“They bind D-type cyclins and are then able to phosphorylate the retinoblastoma protein to relieve the transcriptional repression of E2F-dependent genes, thereby driving cells through the G1 phase into the S phase of the cell cycle (Classon and Harlow, 2002; Ekholm and Reed, 2000; Matsushime et al., 1994).”
BackgroundLifetime Risks of Common Cancers Among Retinoblastoma Survivors
Fletcher, O., Easton, D., Anderson, K., Gilham, C., Jay, M., & Peto, J. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh058 · Cited by 312
“† Epithelial cancers considered in Table 2. Histologic details of the 30 epithelial cancer deaths among hereditary retinoblastoma survivors are as fo llows: lung (n 14): carcinoma not otherwise specified (5), oat cell carcinoma (2), small-cell carcinoma (1), alveolar adenocarcinoma (1), no histology (5); bladder (n 5)…”
BackgroundInfluentialEpigenetic and Chromatin Modifiers As Targeted Therapy of Hematologic Malignancies
Bhalla, K. N. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.16.600 · Cited by 308
Mouse models for human lung cancer
Meuwissen, R., & Berns, A. (2005) · Genes & Development · doi:10.1101/gad.1284505 · Cited by 302
“This is a feature pulmonary NE tumors have in common with tumors derived from neural or NE cells (Vooijs et al. 1998; Marino et al. 2000; Classon and Harlow 2002).”
MDM2 Promotes Proteasome-Dependent Ubiquitin-Independent Degradation of Retinoblastoma Protein
Sdek, P., Ying, H., Chang, D. L. F., Qiu, W., Zheng, H., Touitou, R., Allday, M. J., & Jim Xiao, Z.-X. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.10.017 · Cited by 288
Molecular stop signs: regulation of cell-cycle arrest by C/EBP transcription factors
Johnson, P. F. (2005) · Journal of Cell Science · doi:10.1242/jcs.02459 · Cited by 288
“p107 and p130 preferentially associate with E2F4 and E2F5, whereas pRB can bind to all the E2Fs (Classon and Harlow, 2002).”
BackgroundInfluentialHenley, S. A., & Dick, F. A. (2012) · Cell Division · doi:10.1186/1747-1028-7-10 · Cited by 281
“A frequent companion to E2F regulation is the recruitment of transcriptional repressors (often that possess chromatin regulating enzymatic activity) to pocket protein-E2F complexes [53].”
BackgroundInfluentialOne hit, two hits, three hits, more? Genomic changes in the development of retinoblastoma
Corson, T. W., & Gallie, B. L. (2007) · Genes, Chromosomes and Cancer · doi:10.1002/gcc.20457 · Cited by 278
“Its complex biology has been rigorously reviewed elsewhere (DiCiommo et al., 2000; Classon and Harlow, 2002), and so we present a very brief synopsis of its core functions here.”
BackgroundThe p16INK4a-RB pathway : molecular link between cellular senescence and tumor suppression
Ohtani, N., Yamakoshi, K., Takahashi, A., & Hara, E. (2004) · The Journal of Medical Investigation · doi:10.2152/jmi.51.146 · Cited by 276
Therapy for Osteosarcoma: Where Do We Go From Here?
Chou, A. J., Geller, D. S., & Gorlick, R. (2008) · Pediatric Drugs · doi:10.2165/00148581-200810050-00005 · Cited by 274
Pituitary Tumor-Transforming Gene: Physiology and Implications for Tumorigenesis
Vlotides, G., Eigler, T., & Melmed, S. (2007) · Endocrine Reviews · doi:10.1210/er.2006-0042 · Cited by 267
CDK6 as a key regulator of hematopoietic and leukemic stem cell activation
Scheicher, R., Hoelbl-Kovacic, A., Bellutti, F., Tigan, A.-S., Prchal-Murphy, M., Heller, G., Schneckenleithner, C., Salazar-Roa, M., Zöchbauer-Müller, S., Zuber, J., et al. (2015) · Blood · doi:10.1182/blood-2014-06-584417 · Cited by 262
“Progression through the G1 phase of the cell cycle is mediated by activation of the CDK4/6-cyclinD complex and subsequent phosphorylation of the retinoblastoma protein, which triggers E2F-dependent transcription.(1,2) CDK4 and CDK6 show 71% amino acid homology and have been considered to fulfill largely redundant func…”
BackgroundWang, L., Pal, S., & Sif, S. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.00923-08 · Cited by 259
“Several reports have previously shown that the levels of RBL1 and RBL2 fluctuate in a cell cycle-dependent manner, while RB1 protein expression remains almost constant (8, 14, 43).”
BackgroundProliferation of Functional Hair Cells in Vivo in the Absence of the Retinoblastoma Protein
Sage, C., Huang, M., Karimi, K., Gutierrez, G., Vollrath, M. A., Zhang, D.-S., García-Añoveros, J., Hinds, P. W., Corwin, J. T., Corey, D. P., et al. (2005) · Science · doi:10.1126/science.1106642 · Cited by 259
Binding of pRB to the PHD Protein RBP2 Promotes Cellular Differentiation
Benevolenskaya, E. V., Murray, H. L., Branton, P., Young, R. A., & Kaelin, W. G. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.05.012 · Cited by 241
Cho, H.-S., Suzuki, T., Dohmae, N., Hayami, S., Unoki, M., Yoshimatsu, M., Toyokawa, G., Takawa, M., Chen, T., Kurash, J. K., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2446 · Cited by 240
Cell type-specific effects of Rb deletion in the murine retina
MacPherson, D., Sage, J., Kim, T., Ho, D., McLaughlin, M. E., & Jacks, T. (2004) · Genes & Development · doi:10.1101/gad.1203304 · Cited by 222
“In addition to regulating S-phase entry, RB also regulates apoptosis and terminal differentiation and has been implicated in still other cellular processes (Lipinski and Jacks 1999; DiCiommo et al. 2000; Classon and Harlow 2002; Chau and Wang 2003).”
BackgroundVirus-specific mechanisms of carcinogenesis in hepatitis C virus associated liver cancer
McGivern, D. R., & Lemon, S. M. (2011) · Oncogene · doi:10.1038/onc.2010.594 · Cited by 219
“, 2000; Classon and Harlow, 2002), Rb also regulates DNA damage responses, the mitotic spindle checkpoint, and apoptosis (Classon and Harlow, 2002; Lentini et al., 2002; Hernando et al., 2004; Khidr and Chen, 2006).”
BackgroundInfluentialPhysiological Relevance of Cell Cycle Kinases
Malumbres, M. (2011) · Physiological Reviews · doi:10.1152/physrev.00025.2010 · Cited by 213
“This repression is commonly mediated through the recruitment of repressor complexes, such as the SWI/SNF complex, histone deacetylases, polycomb group proteins as well as methylases, and the binding and inactivation of transcription factors such as the E2F family (52, 206).”
BackgroundControl of glutamine metabolism by the tumor suppressor Rb
Reynolds, M. R., Lane, A. N., Robertson, B., Kemp, S., Liu, Y., Hill, B. G., Dean, D. C., & Clem, B. F. (2014) · Oncogene · doi:10.1038/onc.2012.635 · Cited by 216
“Importantly, the entire Rb family can be suppressed by common mutations in human cancers ( e.g. p16 INK4A (24, 25)) and we thus elected to continue our studies on the metabolic effects of Rb dysfunction by directly comparing the Rb WT and the fully Rb-deficient TKO cells.”
The breast cancer susceptibility genes (BRCA) in breast and ovarian cancers
Paul, A. (2014) · Frontiers in Bioscience · doi:10.2741/4230 · Cited by 212
“showed that the BRCA1-mediated growth inhibition depends on Rb protein (110), a wellknown tumor suppressor that controls growth by regulating progression through the cell cycle (110, 111).”
STRUCTURE-FUNCTION OF THE TUMOR SUPPRESSOR BRCA1
Clark, S. L., Rodriguez, A. M., Snyder, R. R., Hankins, G. D. V., & Boehning, D. (2012) · Computational and Structural Biotechnology Journal · doi:10.5936/csbj.201204005 · Cited by 214
A ‘higher order’ of telomere regulation: telomere heterochromatin and telomeric RNAs
Schoeftner, S., & Blasco, M. A. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.197 · Cited by 213
“A major tumour suppressor pathway in mammals is centred on the family of retinoblastoma (RB) proteins, consisting of RB1, RBL1 and RBL2 (Weinberg, 1995; Lipinski and Jacks, 1999; Classon and Harlow, 2002).”
BackgroundThe c‐myc Promoter: Still MysterY and Challenge
(2008) · Advances in Cancer Research · doi:10.1016/s0065-230x(07)99004-1 · Cited by 211
Retinoblastoma: Revisiting the model prototype of inherited cancer
Lohmann, D. R., & Gallie, B. L. (2004) · American Journal of Medical Genetics Part C: Seminars in Medical Genetics · doi:10.1002/ajmg.c.30024 · Cited by 203
Ubiquitin-independent degradation of proteins by the proteasome
Jariel-Encontre, I., Bossis, G., & Piechaczyk, M. (2008) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2008.05.004 · Cited by 201
Leroi, A. M., Koufopanou, V., & Burt, A. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1016 · Cited by 193
Nebenfuehr, S., Kollmann, K., & Sexl, V. (2020) · International Journal of Cancer · doi:10.1002/ijc.33054 · Cited by 187
KIF14 is a candidate oncogene in the 1q minimal region of genomic gain in multiple cancers
Corson, T. W., Huang, A., Tsao, M.-S., & Gallie, B. L. (2005) · Oncogene · doi:10.1038/sj.onc.1208641 · Cited by 184
“The initiating event in retinoblastoma development is the loss of function of both alleles of the prototypic tumor suppressor gene, RB1, which encodes a key cell-cycle negative regulatory transcription factor, pRB (Classon and Harlow, 2002).”
BackgroundFOXM1 (Forkhead box M1) in Tumorigenesis
(2013) · Advances in Cancer Research · doi:10.1016/b978-0-12-407190-2.00016-2 · Cited by 184
“6.1) (Beijersbergen and Bernards, 1996; Burkhart and Sage, 2008; Chan et al., 2001; Chinnam and Goodrich, 2011; Classon and Harlow, 2002; Cobrinik, 1996, 2005; DeGregori, 2004; Du and Pogoriler, 2006; Dyson, 1998; Fiorentino et al., 2013; Frolov and Dyson, 2004; Giacinti and Giordano, 2006; Gordon,…”
InfluentialBéguelin, W., Rivas, M. A., Calvo Fernández, M. T., Teater, M., Purwada, A., Redmond, D., Shen, H., Challman, M. F., Elemento, O., Singh, A., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01029-x · Cited by 183
Christensen, J. (2005) · Nucleic Acids Research · doi:10.1093/nar/gki855 · Cited by 182
“In the majority of human cancers, the control of E2F transcriptional regulation is deregulated and is caused either by direct mutational inactivation of the RB1 gene or through aberrant expression of genes regulating pRB (3).”
BackgroundDorner, D., Vlcek, S., Foeger, N., Gajewski, A., Makolm, C., Gotzmann, J., Hutchison, C. J., & Foisner, R. (2006) · The Journal of Cell Biology · doi:10.1083/jcb.200511149 · Cited by 179
Binné, U. K., Classon, M. K., Dick, F. A., Wei, W., Rape, M., Kaelin, W. G., Näär, A. M., & Dyson, N. J. (2007) · Nature Cell Biology · doi:10.1038/ncb1532 · Cited by 175
“dtd" [ ]> The retinoblastoma protein (p RB ) negatively regulates the progression from G1 to S phase of the cell cycle, in part, by repressing E2F-dependent transcriptio”
Self-citationNon-canonical functions of the RB protein in cancer
Dick, F. A., Goodrich, D. W., Sage, J., & Dyson, N. J. (2018) · Nature Reviews Cancer · doi:10.1038/s41568-018-0008-5 · Cited by 168
The search for the retinoblastoma cell of origin
Dyer, M. A., & Bremner, R. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1545 · Cited by 170
“E2F transcription factors regulate other genes required for S-phase and cell-cycle progressio”
BackgroundSEREGARD, S. (2004) · Ophthalmology · doi:10.1016/j.ophtha.2003.10.023 · Cited by 170
The search for the retinoblastoma cell of origin
Dyer, M. A., & Bremmer, R. (2005) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2005.05.013 · Cited by 168
Updates on the CDK4/6 Inhibitory Strategy and Combinations in Breast Cancer
Sobhani, N., D’Angelo, A., Pittacolo, M., Roviello, G., Miccoli, A., Corona, S. P., Bernocchi, O., Generali, D., & Otto, T. (2019) · Cells · doi:10.3390/cells8040321 · Cited by 167
“In most human cancer cells, this pathway is impaired due to either the loss of Rb itself, overexpression of cyclin D1, mutation of CDK4 (causing insensitivity to CDK inhibitors) or the loss of p16Ink4a [4].”
BackgroundIdentification of cell cycle–arrested quiescent osteoclast precursors in vivo
Mizoguchi, T., Muto, A., Udagawa, N., Arai, A., Yamashita, T., Hosoya, A., Ninomiya, T., Nakamura, H., Yamamoto, Y., Kinugawa, S., et al. (2009) · Journal of Cell Biology · doi:10.1083/jcb.200806139 · Cited by 164
“D-type cyclins are shown to associate with Cdk4 or 6 ( Weinberg, 1995 ; Morgan, 1997 ; Classon and Harlow, 2002 ).”
Involvement of E2F transcription factor family in cancer
Tsantoulis, P. K., & Gorgoulis, V. G. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2005.08.005 · Cited by 163
“The pocket protein family includes the retinoblastoma protein, pRb, which is the most prominent member [40], p107 [41] and p130 [42].”
BackgroundLongworth, M. S., & Laimins, L. A. (2004) · Journal of Virology · doi:10.1128/jvi.78.7.3533-3541.2004 · Cited by 163
Abemaciclib: a CDK4/6 inhibitor for the treatment of HR+/HER2– advanced breast cancer
Corona, S. P., & Generali, D. (2018) · Drug Design, Development and Therapy · doi:10.2147/dddt.s137783 · Cited by 157
Aberrant Regulation of Survivin by the RB/E2F Family of Proteins
Jiang, Y., Saavedra, H. I., Holloway, M. P., Leone, G., & Altura, R. A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m404496200 · Cited by 160
NRAS mutant melanoma: Towards better therapies
Randic, T., Kozar, I., Margue, C., Utikal, J. S., & Kreis, S. (2021) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2021.102238 · Cited by 189
“mediated hyperphosphorylation and inactivation of the retinoblastoma protein (RB) releases E2F-induced transcriptional activity [35-37], which in turn leads to the expression of E-type cyclins (cyclin E1 and E2) (Fig.”
BackgroundProteasome system of protein degradation and processing
Sorokin, A. V., Kim, E. R., & Ovchinnikov, L. P. (2009) · Biochemistry (Moscow) · doi:10.1134/s000629790913001x · Cited by 156
Sun, A., Bagella, L., Tutton, S., Romano, G., & Giordano, A. (2007) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21609 · Cited by 153
“This region is not substrate for hyperphosphorylaton by cdk2/ cyclin A and cdk2/cyclin E [DeLuca et al., 1997; Classon and Harlow, 2002].”
BackgroundArima, Y., Inoue, Y., Shibata, T., Hayashi, H., Nagano, O., Saya, H., & Taya, Y. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5680 · Cited by 151
“The negative regulatory activity of Rb is largely viewed as an effect on cell cycle progression that influences tumorigenesis; hypophosphorylated Rb binds E2F and inhibits E2F transcriptional activity at the promoters of many genes involved in DNA replication ( 20 , 38).”
BackgroundDetection of miR-106a in gastric carcinoma and its clinical significance
Xiao, B., Guo, J., Miao, Y., Jiang, Z., Huan, R., Zhang, Y., Li, D., & Zhong, J. (2008) · Clinica Chimica Acta · doi:10.1016/j.cca.2008.10.021 · Cited by 157
“The Rb family of tumor suppressors and the E2F1 family of transcription factors are involved in the maintenance of many cellular processes including regulation of the cell cycle, DNA replication, and apoptosis [27,28].”
BackgroundMunakata, T., Nakamura, M., Liang, Y., Li, K., & Lemon, S. M. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0505605102 · Cited by 159
Uziel, T., Zindy, F., Xie, S., Lee, Y., Forget, A., Magdaleno, S. M., Rehg, J. E., Calabrese, C. R., Solecki, D. J., Eberhart, C. G., et al. (2005) · Genes & Development · doi:10.1101/gad.1368605 · Cited by 160
“…family of proteins (Rb, p130, and p107) that govern both cell cycle exit and differentiation in many biological settings (Sellers et al. 1998; Morris and Dyson 2001; Müller et al. 2001; Trimarchi and Lees 2002; Classon and Harlow 2002; Thomas et al. 2003; Bracken et al. 2004; Cam et al. 2004).”
BackgroundRuiz, S., Santos, M., Segrelles, C., Leis, H., Jorcano, J. L., Berns, A., Paramio, J. M., & Vooijs, M. (2004) · Development · doi:10.1242/dev.01148 · Cited by 147
“The Rb family of pocket proteins comprises three members pRb, p107 and p130 that have unique and overlapping functions in cell cycle control, differentiation and inhibition of oncogenic transformation (Classon and Harlow, 2002).”
BackgroundHepatitis C Virus Induces E6AP-Dependent Degradation of the Retinoblastoma Protein
Munakata, T., Liang, Y., Kim, S., McGivern, D. R., Huibregtse, J., Nomoto, A., & Lemon, S. M. (2007) · PLoS Pathogens · doi:10.1371/journal.ppat.0030139 · Cited by 148
“While the abundance of pRb may be regulated through a diversity of mechanisms, its activity in controlling E2F transcription factors is largely regulated by phosphorylation [14].”
BackgroundProtein arginine methyltransferase 5 is essential for growth of lung cancer cells
Gu, Z., Gao, S., Zhang, F., Wang, Z., Ma, W., Davis, R. E., & Wang, Z. (2012) · Biochemical Journal · doi:10.1042/bj20120768 · Cited by 160
Teh, J. L. F., & Aplin, A. E. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-1967 · Cited by 156
Du, W., & Pogoriler, J. E. (2006) · Oncogene · doi:10.1038/sj.onc.1209651 · Cited by 177
“Although simplified models suggest that the Rb/E2F complexes present during quiescence or G0 are replaced with free E2Fs at the G1/S transition, the actual composition of these complexes appears to vary with the cell cycle (Classon and Harlow, 2002; Bracken et al., 2004).”
BackgroundChen, J., Huang, X., Halicka, D., Brodsky, S., Avram, A., Eskander, J., Bloomgarden, N. A., Darzynkiewicz, Z., & Goligorsky, M. S. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00364.2005 · Cited by 142
Dong, C., Wilhelm, D., & Koopman, P. A. (2004) · Cytogenetic and Genome Research · doi:10.1159/000078217 · Cited by 142
“, 2003), components of signal transduction pathways such as the SHH, WNT and NOTCH pathways (Wicking et al., 1999; Classon and Harlow, 2002; Lustig and Behrens, 2003), and transcription factors such as RUNX (Lund and van Lohuizen, 2002) and AP-1 (Jochum et al.”
BackgroundBisova, K., Krylov, D. M., & Umen, J. G. (2005) · Plant Physiology · doi:10.1104/pp.104.054155 · Cited by 141
“Animals and plants encode one or more RBRs andmultiple E2F/DP family members (Gutierrez, 1998, 2002; Harbour and Dean, 2000; Classon and Harlow, 2002; De Veylder et al., 2002, 2003; Dewitte and Murray, 2003).”
BackgroundCause-Specific Mortality in Long-Term Survivors of Retinoblastoma
Yu, C., Tucker, M. A., Abramson, D. H., Furukawa, K., Seddon, J. M., Stovall, M. A., Fraumeni, J. F., & Kleinerman, R. A. (2009) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djp046 · Cited by 155
Boiko, A. D., Porteous, S., Razorenova, O. V., Krivokrysenko, V. I., Williams, B. R. G., & Gudkov, A. V. (2006) · Genes & Development · doi:10.1101/gad.1372606 · Cited by 152
“Similarly to Rb-deficient mice, where it was demonstrated that only multiple knockouts of Rb family members made mice prone to spontaneous tumorigenesis (Classon and Harlow 2002), long-term studies as well as interbreeding experiments between knockout members of the tob family are required to uncover their tumor suppr…”
BackgroundThe retinoblastoma gene pathway regulates the postmitotic state of hair cells of the mouse inner ear
Mantela, J., Jiang, Z., Ylikoski, J., Fritzsch, B., Zacksenhaus, E., & Pirvola, U. (2005) · Development · doi:10.1242/dev.01834 · Cited by 137
Essential role of retinoblastoma protein in mammalian hair cell development and hearing
Sage, C., Huang, M., Vollrath, M. A., Brown, M. C., Hinds, P. W., Corey, D. P., Vetter, D. E., & Chen, Z.-Y. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510631103 · Cited by 137
Amin, A. R. M. R., Karpowicz, P. A., Carey, T. E., Arbiser, J. L., Nahta, R., Chen, Z. G., Dong, J., Küçük, Ö., Khan, G. N., Huang, G. S., et al. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.02.005 · Cited by 166
“In addition to controlling cell cycle progression, pRB is lso involved in the regulation of DNA replication, differentiation, nd apoptosis [7].”
BackgroundInfluentialSelective degradation of CDK6 by a palbociclib based PROTAC
Rana, S., Bendjennat, M., Kour, S., King, H. M., Kizhake, S., Zahid, M., & Natarajan, A. (2019) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2019.03.035 · Cited by 135
Proapoptotic Function of the Retinoblastoma Tumor Suppressor Protein
Ianari, A., Natale, T., Calo, E., Ferretti, E., Alesse, E., Screpanti, I., Haigis, K., Gulino, A., & Lees, J. A. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.01.026 · Cited by 135
“In addition to its role in cell-cycle control, pRB has been implicated in regulating a wide variety of cellular processes, including DNA replication, differentiation, and apoptosis (Classon and Harlow, 2002).”
New insights into human papillomavirus-associated head and neck squamous cell carcinoma.
Boscolo‐Rizzo, P., Mistro, A. D., Bussu, F., Lupato, V., Baboçi, L., Almadori, G., Mosto, M. C. D., & Paludetti, G. (2013) · Europe PMC (PubMed Central) · Cited by 135
Induction of microRNAome deregulation in rat liver by long-term tamoxifen exposure
Pogribny, I. P., Tryndyak, V., Boyko, A., Rodriguez‐Juarez, R., Beland, F. A., & Kovalchuk, O. (2007) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2006.12.006 · Cited by 145
Rb intrinsically promotes erythropoiesis by coupling cell cycle exit with mitochondrial biogenesis
Sankaran, V. G., Orkin, & Walkley, C. R. (2008) · Genes & Development · doi:10.1101/gad.1627208 · Cited by 133
“The retinoblastoma protein (Rb) is a central regulator of the G1-to-S-phase transition of the cell cycle (Classon and Harlow 2002).”
BackgroundCancer initiation and progression: Involvement of stem cells and the microenvironment
Tysnes, B. B., & BJERKVIG, R. (2007) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2007.01.001 · Cited by 164
Unusually effective microRNA targeting within repeat-rich coding regions of mammalian mRNAs
Schnall-Levin, M., Rissland, O. S., Johnston, W. K., Perrimon, N., Bartel, D. P., & Berger, B. (2011) · Genome Research · doi:10.1101/gr.121210.111 · Cited by 133
“13 which encodes the well-characterized tumor-suppressor protein (Hanahan and Weinberg 2000; Classon and Harlow 2002), also contains sites to miR-181 in both its ORF (two 8mers and one 7mer) and 3'UTR (one nonconserved 7mer).”
BackgroundA comprehensive modular map of molecular interactions in RB/E2F pathway
Calzone, L., Gelay, A., Zinovyev, A., Radvanyi, F., & Barillot, E. (2008) · Molecular Systems Biology · doi:10.1038/msb.2008.7 · Cited by 132
“Finally, the importance of the RB/E2F pathway in tumour formation based on genetic or epigenetic arguments, has been confirmed by in vivo experiments using transgenic mice (Classon and Harlow, 2002).”
BackgroundTumor Suppressor Genes in Breast Cancer
Oliveira, A. M., Ross, J. S., & Fletcher, J. A. (2005) · Pathology Patterns Reviews · doi:10.1309/5xw3l8lu445qwgqr · Cited by 154
Mittal, K., Chen, F., Wei, J., Rijhvani, K., Kurvathi, R., Streck, D. L., Dermody, J. J., & Törüner, G. (2009) · Modern Pathology · doi:10.1038/modpathol.2009.96 · Cited by 129
“Loss of chromosome 13, in which RB-1 is located, is a frequently reported finding in leiomyosarcomas”
BackgroundMolecular signature of oncogenic ras-induced senescence
Mason, D. X., Jackson, T. J., & Lin, A. W. (2004) · Oncogene · doi:10.1038/sj.onc.1208172 · Cited by 127
“We next examined the Rb family member proteins, Rb, p107 and p130, which play an important role in mediating growth suppression signals in nonproliferating cells (Classon and Harlow, 2002).”
BackgroundCerón, J., Rual, J.-F. M., Chandra, A., Dupuy, D., Vidal, M., & van den Heuvel, S. (2007) · BMC Developmental Biology · doi:10.1186/1471-213x-7-30 · Cited by 126
“The frequency of mutations in the Rb gene itself varies greatly between different tumor types, which likely relates to expression levels of other members of the Rb family (p130 and p107) that are closely related in structure and show partly redundant functions in vivo [4].”
BackgroundAn updated overview of HPV-associated head and neck carcinomas
Zaravinos, A. (2014) · Oncotarget · doi:10.18632/oncotarget.1934 · Cited by 134
Metadata
- Authors
- Classon, M., & Harlow, E.
- Affiliations
- Harvard University (US)
- ORCID
- Classon, Marie
- Venue
- Nature Reviews Cancer
- Published
- 2002-12-01
- Volume
- 2
- Issue
- 12
- Pages
- 910-917
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W1998492363
- Cited by
- 738
- References
- 133
- Citations by year
- 2026: 5 · 2025: 10 · 2024: 19 · 2023: 13 · 2022: 20 · 2021: 18 · 2020: 31 · 2019: 18 · 2018: 15 · 2017: 28 · 2016: 24 · 2015: 32 · 2014: 35 · 2013: 23 · 2012: 42
- FWCI
- 4.74
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Health Sciences › Medicine › Ophthalmology › Ocular Oncology and Treatments
- Health Sciences › Medicine › Ophthalmology › Retinal Development and Disorders
- Keywords
- retinoblastoma protein, RB1, tumour suppressor, cell proliferation, cell differentiation, cell survival, Rb family proteins, protein redundancy, knockout mice, development (biology), cancer
- MeSH terms
- Animals, Cell Division, Humans, Nuclear Proteins, Phenotype, Phosphoproteins, Proteins, Retinoblastoma, Signal Transduction, Retinoblastoma Protein, Genes, Retinoblastoma, Mice, Knockout, Retinoblastoma-Like Protein p130, Retinoblastoma-Like Protein p107, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.